Literature DB >> 22973031

The crystal structure of a coxsackievirus B3-RD variant and a refined 9-angstrom cryo-electron microscopy reconstruction of the virus complexed with decay-accelerating factor (DAF) provide a new footprint of DAF on the virus surface.

Joshua D Yoder1, Javier O Cifuente, Jieyan Pan, Jeffrey M Bergelson, Susan Hafenstein.   

Abstract

The coxsackievirus-adenovirus receptor (CAR) and decay-accelerating factor (DAF) have been identified as cellular receptors for coxsackievirus B3 (CVB3). The first described DAF-binding isolate was obtained during passage of the prototype strain, Nancy, on rhabdomyosarcoma (RD) cells, which express DAF but very little CAR. Here, the structure of the resulting variant, CVB3-RD, has been solved by X-ray crystallography to 2.74 Å, and a cryo-electron microscopy reconstruction of CVB3-RD complexed with DAF has been refined to 9.0 Å. This new high-resolution structure permits us to correct an error in our previous view of DAF-virus interactions, providing a new footprint of DAF that bridges two adjacent protomers. The contact sites between the virus and DAF clearly encompass CVB3-RD residues recently shown to be required for binding to DAF; these residues interact with DAF short consensus repeat 2 (SCR2), which is known to be essential for virus binding. Based on the new structure, the mode of the DAF interaction with CVB3 differs significantly from the mode reported previously for DAF binding to echoviruses.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22973031      PMCID: PMC3497627          DOI: 10.1128/JVI.01592-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  69 in total

1.  Physical principles in the construction of regular viruses.

Authors:  D L CASPAR; A KLUG
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1962

2.  Interaction with coxsackievirus and adenovirus receptor, but not with decay-accelerating factor (DAF), induces A-particle formation in a DAF-binding coxsackievirus B3 isolate.

Authors:  Aaron M Milstone; JenniElizabeth Petrella; Melissa D Sanchez; Mariam Mahmud; J Charles Whitbeck; Jeffrey M Bergelson
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

Review 3.  Coxsackievirus myocarditis: interplay between virus and host in the pathogenesis of heart disease.

Authors:  Patricia E Tam
Journal:  Viral Immunol       Date:  2006       Impact factor: 2.257

4.  Crystallography & NMR system: A new software suite for macromolecular structure determination.

Authors:  A T Brünger; P D Adams; G M Clore; W L DeLano; P Gros; R W Grosse-Kunstleve; J S Jiang; J Kuszewski; M Nilges; N S Pannu; R J Read; L M Rice; T Simonson; G L Warren
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1998-09-01

5.  A genetically engineered attenuated coxsackievirus B3 strain protects mice against lethal infection.

Authors:  M Dan; J K Chantler
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

6.  Structural and functional insights into the interaction of echoviruses and decay-accelerating factor.

Authors:  David M Pettigrew; David T Williams; David Kerrigan; David J Evans; Susan M Lea; David Bhella
Journal:  J Biol Chem       Date:  2005-11-04       Impact factor: 5.157

7.  Inhibition of coxsackie B virus infection by soluble forms of its receptors: binding affinities, altered particle formation, and competition with cellular receptors.

Authors:  Ian G Goodfellow; David J Evans; Anna M Blom; Dave Kerrigan; J Scott Miners; B Paul Morgan; O Brad Spiller
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

8.  Tissue tropism of recombinant coxsackieviruses in an adult mouse model.

Authors:  Heli Harvala; Hannu Kalimo; Jeffrey Bergelson; Glyn Stanway; Timo Hyypiä
Journal:  J Gen Virol       Date:  2005-07       Impact factor: 3.891

9.  Attenuating mutations in coxsackievirus B3 map to a conformational epitope that comprises the puff region of VP2 and the knob of VP3.

Authors:  E Stadnick; M Dan; A Sadeghi; J K Chantler
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

10.  Characterization of early steps in the poliovirus infection process: receptor-decorated liposomes induce conversion of the virus to membrane-anchored entry-intermediate particles.

Authors:  Tobias J Tuthill; Doryen Bubeck; David J Rowlands; James M Hogle
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

View more
  28 in total

1.  Seneca Valley virus attachment and uncoating mediated by its receptor anthrax toxin receptor 1.

Authors:  Lin Cao; Ran Zhang; Tingting Liu; Zixian Sun; Mingxu Hu; Yuna Sun; Lingpeng Cheng; Yu Guo; Sheng Fu; Junjie Hu; Xiangmin Li; Chengqi Yu; Hanyang Wang; Huanchun Chen; Xueming Li; Elizabeth E Fry; David I Stuart; Ping Qian; Zhiyong Lou; Zihe Rao
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-04       Impact factor: 11.205

2.  Specificity of coxsackievirus B3 interaction with human, but not murine, decay-accelerating factor: replacement of a single residue within short consensus repeat 2 prevents virus attachment.

Authors:  Jieyan Pan; Lili Zhang; Lindsey J Organtini; Susan Hafenstein; Jeffrey M Bergelson
Journal:  J Virol       Date:  2014-11-12       Impact factor: 5.103

3.  In vitro interaction between coxsackievirus B3 VP1 protein and human pleckstrin homology domain retinal protein (PHR1).

Authors:  Ying Zhou; Zhiqin Zhang; Hongluan Wang; Yanhua Xia; Xiuzhen Li; Yan Yan; Weiwen Zou; Lingbing Zeng; Xiaotian Huang
Journal:  Virus Genes       Date:  2015-08-30       Impact factor: 2.332

Review 4.  Is a multivalent hand, foot, and mouth disease vaccine feasible?

Authors:  Michel Klein; Pele Chong
Journal:  Hum Vaccin Immunother       Date:  2015-05-26       Impact factor: 3.452

5.  Echovirus 1 entry into polarized Caco-2 cells depends on dynamin, cholesterol, and cellular factors associated with macropinocytosis.

Authors:  Sophie E Krieger; Chonsaeng Kim; Lili Zhang; Varpu Marjomaki; Jeffrey M Bergelson
Journal:  J Virol       Date:  2013-06-05       Impact factor: 5.103

Review 6.  Blood Groups in Infection and Host Susceptibility.

Authors:  Laura Cooling
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

7.  Interspecies differences in virus uptake versus cardiac function of the coxsackievirus and adenovirus receptor.

Authors:  Fabian Freiberg; Martina Sauter; Sandra Pinkert; Thirupugal Govindarajan; Joanna Kaldrack; Meghna Thakkar; Henry Fechner; Karin Klingel; Michael Gotthardt
Journal:  J Virol       Date:  2014-04-16       Impact factor: 5.103

8.  Site-specific targeting of enterovirus capsid by functionalized monodisperse gold nanoclusters.

Authors:  Varpu Marjomäki; Tanja Lahtinen; Mari Martikainen; Jaakko Koivisto; Sami Malola; Kirsi Salorinne; Mika Pettersson; Hannu Häkkinen
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-13       Impact factor: 11.205

9.  Kinetic and structural analysis of coxsackievirus B3 receptor interactions and formation of the A-particle.

Authors:  Lindsey J Organtini; Alexander M Makhov; James F Conway; Susan Hafenstein; Steven D Carson
Journal:  J Virol       Date:  2014-03-12       Impact factor: 5.103

Review 10.  Coxsackievirus B3-Its Potential as an Oncolytic Virus.

Authors:  Anja Geisler; Ahmet Hazini; Lisanne Heimann; Jens Kurreck; Henry Fechner
Journal:  Viruses       Date:  2021-04-21       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.